Market Closed -
Euronext Paris
11:35:25 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
867
EUR
|
-0.12%
|
|
-1.70%
|
+4.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,108
|
2,079
|
2,246
|
1,737
|
1,716
|
1,799
|
-
|
-
|
Enterprise Value (EV)
1 |
2,084
|
2,003
|
2,168
|
1,907
|
1,716
|
1,919
|
1,861
|
1,799
|
P/E ratio
|
40.2
x
|
41.4
x
|
31.5
x
|
23
x
|
23.2
x
|
22.2
x
|
19.9
x
|
-
|
Yield
|
0.54%
|
0.62%
|
0.82%
|
0.96%
|
1.02%
|
1.11%
|
1.2%
|
-
|
Capitalization / Revenue
|
3.8
x
|
3.86
x
|
3.71
x
|
2.47
x
|
2.38
x
|
2.3
x
|
2.2
x
|
-
|
EV / Revenue
|
3.76
x
|
3.72
x
|
3.58
x
|
2.71
x
|
2.38
x
|
2.46
x
|
2.28
x
|
-
|
EV / EBITDA
|
-
|
-
|
18.5
x
|
-
|
12.9
x
|
13.2
x
|
11.9
x
|
10
x
|
EV / FCF
|
44.2
x
|
23.2
x
|
33.7
x
|
74.3
x
|
-
|
27.4
x
|
22.2
x
|
-
|
FCF Yield
|
2.26%
|
4.31%
|
2.97%
|
1.35%
|
-
|
3.66%
|
4.5%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,308
|
2,310
|
2,312
|
2,087
|
2,080
|
2,089
|
-
|
-
|
Reference price
2 |
923.0
|
905.0
|
975.0
|
837.0
|
830.0
|
867.0
|
867.0
|
867.0
|
Announcement Date
|
5/5/20
|
4/30/21
|
4/29/22
|
5/2/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
554.3
|
538.3
|
606.1
|
703
|
721.1
|
781.6
|
817.4
|
-
|
EBITDA
1 |
-
|
-
|
117.5
|
-
|
133
|
145.6
|
155.8
|
180
|
EBIT
1 |
73.04
|
71
|
93.59
|
101.9
|
111.4
|
121.8
|
131.8
|
-
|
Operating Margin
|
13.18%
|
13.19%
|
15.44%
|
14.5%
|
15.45%
|
15.58%
|
16.13%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
93.67
|
-
|
100.2
|
114
|
133
|
151
|
Net income
1 |
53.04
|
50.58
|
71.71
|
76.02
|
74.6
|
85.8
|
95.1
|
113
|
Net margin
|
9.57%
|
9.4%
|
11.83%
|
10.81%
|
10.34%
|
10.98%
|
11.64%
|
-
|
EPS
2 |
22.96
|
21.87
|
31.00
|
36.41
|
35.71
|
39.12
|
43.48
|
-
|
Free Cash Flow
1 |
47.15
|
86.24
|
64.34
|
25.66
|
-
|
70.15
|
83.7
|
-
|
FCF margin
|
8.51%
|
16.02%
|
10.62%
|
3.65%
|
-
|
8.98%
|
10.24%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
54.74%
|
-
|
-
|
48.2%
|
53.71%
|
-
|
FCF Conversion (Net income)
|
88.89%
|
170.5%
|
89.72%
|
33.75%
|
-
|
81.76%
|
88.01%
|
-
|
Dividend per Share
2 |
5.000
|
5.600
|
8.000
|
8.000
|
8.500
|
9.635
|
10.38
|
-
|
Announcement Date
|
5/5/20
|
4/30/21
|
4/29/22
|
5/2/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
170
|
-
|
120
|
61.4
|
-
|
Net Cash position
1 |
24.2
|
76.4
|
77.3
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.8241
x
|
0.394
x
|
-
|
Free Cash Flow
1 |
47.2
|
86.2
|
64.3
|
25.7
|
-
|
70.2
|
83.7
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
18.3%
|
-
|
15.9%
|
14.9%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
9.32%
|
-
|
8.7%
|
8.5%
|
-
|
Assets
1 |
-
|
-
|
-
|
815.3
|
-
|
986.2
|
1,119
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
20.8
|
21.1
|
-
|
21
|
21.5
|
24
|
Capex / Sales
|
-
|
-
|
3.43%
|
3%
|
-
|
2.69%
|
2.63%
|
-
|
Announcement Date
|
5/5/20
|
4/30/21
|
4/29/22
|
5/2/23
|
4/11/24
|
-
|
-
|
-
|
Average target price
1,115
EUR Spread / Average Target +28.60% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.46% | 1.94B | | +14.70% | 65.04B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B | | -20.82% | 13.62B |
Other Specialty Chemicals
|